← Back to headlines
Lilly's Jaypirca Shows Extended Progression-Free Survival in CLL Treatment
New data for Lilly's drug Jaypirca indicates extended progression-free survival in patients with Chronic Lymphocytic Leukemia, marking a potential advancement in treatment.
13 Apr, 12:13 — 13 Apr, 12:13
Sources
Showing 1 of 1 sources
Related Stories
'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Study Reveals Early Human Quarrying in South Africa 220,000 Years Ago
just now
Portugal Doubles Green Jobs in Three Years
27m ago
Wildlife SOS Secures Open Wells in Junnar to Prevent Accidents
29m ago